| Year |
Citation |
Score |
| 2020 |
Fukuda-Doi M, Yamamoto H, Koga M, Palesch YY, Durkalski-Mauldin VL, Qureshi AI, Yoshimura S, Okazaki S, Miwa K, Okada Y, Ueda T, Okuda S, Nakahara J, Suzuki N, Toyoda K. Sex Differences in Blood Pressure-Lowering Therapy and Outcomes Following Intracerebral Hemorrhage: Results From ATACH-2. Stroke. STROKEAHA120029770. PMID 32623977 DOI: 10.1161/Strokeaha.120.029770 |
0.334 |
|
| 2020 |
Okazaki S, Yamamoto H, Foster LD, Fukuda-Doi M, Koga M, Ihara M, Toyoda K, Palesch YY, Qureshi AI. Late Neurological Deterioration after Acute Intracerebral Hemorrhage: A post hoc Analysis of the ATACH-2 Trial. Cerebrovascular Diseases (Basel, Switzerland). 1-6. PMID 32045911 DOI: 10.1159/000506117 |
0.36 |
|
| 2019 |
Chalos V, van der Ende NAM, Lingsma HF, Mulder MJHL, Venema E, Dijkland SA, Berkhemer OA, Yoo AJ, Broderick JP, Palesch YY, Yeatts SD, Roos YBWEM, van Oostenbrugge RJ, van Zwam WH, Majoie CBLM, et al. National Institutes of Health Stroke Scale: An Alternative Primary Outcome Measure for Trials of Acute Treatment for Ischemic Stroke. Stroke. STROKEAHA119026791. PMID 31795895 DOI: 10.1161/Strokeaha.119.026791 |
0.464 |
|
| 2019 |
Farrant M, Easton JD, Adelman EE, Cucchiara BL, Barsan WG, Tillman HJ, Elm JJ, Kim AS, Lindblad AS, Palesch YY, Zhao W, Pauls K, Walsh KB, Martí-Fàbregas J, Bernstein RA, et al. Assessment of the End Point Adjudication Process on the Results of the Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial: A Secondary Analysis. Jama Network Open. 2: e1910769. PMID 31490536 DOI: 10.1001/jamanetworkopen.2019.10769 |
0.619 |
|
| 2019 |
Moullaali TJ, Wang X, Martin RH, Shipes VB, Robinson TG, Chalmers J, Suarez JI, Qureshi AI, Palesch YY, Anderson CS. Blood pressure control and clinical outcomes in acute intracerebral haemorrhage: a preplanned pooled analysis of individual participant data. The Lancet. Neurology. 18: 857-864. PMID 31397290 DOI: 10.1016/S1474-4422(19)30196-6 |
0.321 |
|
| 2019 |
Johnston SC, Elm JJ, Easton JD, Farrant M, Barsan WG, Kim AS, Lindblad AS, Palesch YY, Zurita KG, Albers GW, Cucchiara BL, Kleindorfer DO, Lutsep HL, Pearson C, Sethi P, et al. Time Course for Benefit and Risk of Clopidogrel and Aspirin after Acute Transient Ischemic Attack and Minor Ischemic Stroke: A Secondary Analysis from the POINT Randomized Trial. Circulation. PMID 31238700 DOI: 10.1161/Circulationaha.119.040713 |
0.643 |
|
| 2019 |
Tillman H, Johnston SC, Farrant M, Barsan W, Elm JJ, Kim AS, Lindblad AS, Palesch YY, Easton JD. Risk for Major Hemorrhages in Patients Receiving Clopidogrel and Aspirin Compared With Aspirin Alone After Transient Ischemic Attack or Minor Ischemic Stroke: A Secondary Analysis of the POINT Randomized Clinical Trial. Jama Neurology. PMID 31034032 DOI: 10.1001/Jamaneurol.2019.0932 |
0.64 |
|
| 2019 |
Selim M, Foster LD, Moy CS, Xi G, Hill MD, Morgenstern LB, Greenberg SM, James ML, Singh V, Clark WM, Norton C, Palesch YY, Yeatts SD. Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trial. The Lancet. Neurology. PMID 30898550 DOI: 10.1016/S1474-4422(19)30069-9 |
0.337 |
|
| 2019 |
Frankel M, Fan L, Yeatts SD, Jeromin A, Vos PE, Wagner AK, Wolf BJ, Pauls Q, Lunney M, Merck LH, Hall CL, Palesch Y, Silbergleit R, David W. The Association of Very Early Serum levels of S100B, GFAP, UCH-L1, and SBDP with Outcome in ProTECT III. Journal of Neurotrauma. PMID 30794101 DOI: 10.1089/Neu.2018.5809 |
0.303 |
|
| 2018 |
Toyoda K, Koga M, Yamamoto H, Foster L, Palesch YY, Wang Y, Sakai N, Hara T, Hsu CY, Itabashi R, Sato S, Fukuda M, Steiner T, Yoon BW, Hanley DF, et al. Clinical outcomes depending on acute blood pressure after cerebral hemorrhage. Annals of Neurology. PMID 30421455 DOI: 10.1002/Ana.25379 |
0.303 |
|
| 2018 |
Moullaali TJ, Wang X, Martin RH, Shipes VB, Qureshi AI, Anderson CS, Palesch YY. Statistical analysis plan for pooled individual patient data from two landmark randomized trials (INTERACT2 and ATACH-II) of intensive blood pressure lowering treatment in acute intracerebral hemorrhage. International Journal of Stroke : Official Journal of the International Stroke Society. 1747493018813695. PMID 30418098 DOI: 10.1177/1747493018813695 |
0.307 |
|
| 2018 |
Kamel H, Longstreth WT, Tirschwell DL, Kronmal RA, Broderick JP, Palesch YY, Meinzer C, Dillon C, Ewing I, Spilker JA, Di Tullio MR, Hod EA, Soliman EZ, Chaturvedi S, Moy CS, et al. The AtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenic stroke randomized trial: Rationale and methods. International Journal of Stroke : Official Journal of the International Stroke Society. 1747493018799981. PMID 30196789 DOI: 10.1177/1747493018799981 |
0.418 |
|
| 2018 |
Cassarly C, Martin RH, Chimowitz M, Peña EA, Ramakrishnan V, Palesch YY. Treatment effect on ordinal functional outcome using piecewise multistate Markov model with unobservable baseline: an application to the modified Rankin scale. Journal of Biopharmaceutical Statistics. 1-16. PMID 29985739 DOI: 10.1080/10543406.2018.1489404 |
0.402 |
|
| 2018 |
Qureshi AI, Palesch YY, Foster LD, Barsan WG, Goldstein JN, Hanley DF, Hsu CY, Moy CS, Qureshi MH, Silbergleit R, Suarez JI, Toyoda K, Yamamoto H. Blood Pressure-Attained Analysis of ATACH 2 Trial. Stroke. PMID 29789395 DOI: 10.1161/Strokeaha.117.019845 |
0.302 |
|
| 2018 |
Johnston SC, Easton JD, Farrant M, Barsan W, Conwit RA, Elm JJ, Kim AS, Lindblad AS, Palesch YY. Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA. The New England Journal of Medicine. PMID 29766750 DOI: 10.1056/Nejmoa1800410 |
0.636 |
|
| 2018 |
Nuño T, Denninghoff KR, Pauls Q, Yeatts SD, Silbergleit R, Palesch YY, Merck LH, Manley G, Wright DW. Reply to: Prehospital Intubation: Further Confounders in Trial Results. Prehospital Emergency Care : Official Journal of the National Association of Ems Physicians and the National Association of State Ems Directors. 1. PMID 29338483 DOI: 10.1080/10903127.2017.1408729 |
0.378 |
|
| 2017 |
Cassarly C, Martin RH, Chimowitz M, Peña EA, Ramakrishnan V, Palesch YY. Comparison of multistate Markov modeling with contemporary outcomes in a reanalysis of the NINDS tissue plasminogen activator for acute ischemic stroke treatment trial. Plos One. 12: e0187050. PMID 29073195 DOI: 10.1371/Journal.Pone.0187050 |
0.427 |
|
| 2017 |
Albers GW, Lansberg MG, Kemp S, Tsai JP, Lavori P, Christensen S, Mlynash M, Kim S, Hamilton S, Yeatts SD, Palesch Y, Bammer R, Broderick J, Marks MP. A multicenter randomized controlled trial of endovascular therapy following imaging evaluation for ischemic stroke (DEFUSE 3). International Journal of Stroke : Official Journal of the International Stroke Society. 12: 896-905. PMID 28946832 DOI: 10.1177/1747493017701147 |
0.418 |
|
| 2017 |
Fan L, Yeatts SD, Foster LD, Khatri P, Tomsick T, Broderick JP, Palesch YY. Endovascular Therapy Demonstrates Benefit over Intravenous Recombinant Tissue Plasminogen Activator Based on Repeatedly Measured National Institutes of Health Stroke Scale. Interventional Neurology. 6: 25-30. PMID 28611830 DOI: 10.1159/000452137 |
0.409 |
|
| 2017 |
Denninghoff KR, Nuño T, Pauls Q, Yeatts SD, Silbergleit R, Palesch YY, Merck LH, Manley GT, Wright DW. Prehospital Intubation is Associated with Favorable Outcomes and Lower Mortality in ProTECT III. Prehospital Emergency Care : Official Journal of the National Association of Ems Physicians and the National Association of State Ems Directors. 1-6. PMID 28489506 DOI: 10.1080/10903127.2017.1315201 |
0.323 |
|
| 2017 |
Simpson KN, Simpson AN, Mauldin PD, Palesch YY, Yeatts SD, Kleindorfer D, Tomsick TA, Foster LD, Demchuk AM, Khatri P, Hill MD, Jauch EC, Jovin TG, Yan B, von Kummer R, et al. Observed Cost and Variations in Short Term Cost-Effectiveness of Therapy for Ischemic Stroke in Interventional Management of Stroke (IMS) III. Journal of the American Heart Association. 6. PMID 28483774 DOI: 10.1161/Jaha.116.004513 |
0.387 |
|
| 2017 |
Cramer SC, Wolf SL, Adams HP, Chen D, Dromerick AW, Dunning K, Ellerbe C, Grande A, Janis S, Lansberg MG, Lazar RM, Palesch YY, Richards L, Roth E, Savitz SI, et al. Stroke Recovery and Rehabilitation Research: Issues, Opportunities, and the National Institutes of Health StrokeNet. Stroke. PMID 28174324 DOI: 10.1161/Strokeaha.116.015501 |
0.767 |
|
| 2017 |
Palesch Y, Ramakrishnan V, Foster L, Martin R, Cassarly C, Barsan W, Moy C, Qureshi A. Antihypertensive treatment of acute cerebral hemorrhage phase iii (ATACH-II) trial: Secondary analysis of Asian and non-Asian subgroups using 24-hour blood pressure profile data Journal of the Neurological Sciences. 381: 643. DOI: 10.1016/J.Jns.2017.08.1811 |
0.341 |
|
| 2016 |
Lansberg MG, Bhat NS, Yeatts SD, Palesch YY, Broderick JP, Albers GW, Lai TL, Lavori PW. Power of an Adaptive Trial Design for Endovascular Stroke Studies: Simulations Using IMS (Interventional Management of Stroke) III Data. Stroke. 47: 2931-2937. PMID 27895297 DOI: 10.1161/Strokeaha.116.015436 |
0.441 |
|
| 2016 |
Tomsick TA, Carrozzella J, Foster L, Hill MD, von Kummer R, Goyal M, Demchuk AM, Khatri P, Palesch Y, Broderick JP, Yeatts SD, Liebeskind DS. Endovascular Therapy of M2 Occlusion in IMS III: Role of M2 Segment Definition and Location on Clinical and Revascularization Outcomes. Ajnr. American Journal of Neuroradiology. PMID 27765740 DOI: 10.3174/Ajnr.A4979 |
0.322 |
|
| 2016 |
Martin RH, Yeatts SD, Hill MD, Moy CS, Ginsberg MD, Palesch YY. ALIAS (Albumin in Acute Ischemic Stroke) Trials: Analysis of the Combined Data From Parts 1 and 2. Stroke; a Journal of Cerebral Circulation. PMID 27462118 DOI: 10.1161/STROKEAHA.116.012825 |
0.365 |
|
| 2016 |
Qureshi AI, Palesch YY, Barsan WG, Hanley DF, Hsu CY, Martin RL, Moy CS, Silbergleit R, Steiner T, Suarez JI, Toyoda K, Wang Y, Yamamoto H, Yoon BW. Intensive Blood-Pressure Lowering in Patients with Acute Cerebral Hemorrhage. The New England Journal of Medicine. PMID 27276234 DOI: 10.1056/Nejmoa1603460 |
0.333 |
|
| 2016 |
Goldstein FC, Caveney A, Hertzberg VS, Silbergleit R, Yeatts S, Palesch Y, Levin H, David W. Very Early Administration of Progesterone Does Not Improve Neuropsychological Outcomes in Subjects with Moderate to Severe TBI. Journal of Neurotrauma. PMID 26973025 DOI: 10.1089/Neu.2015.4313 |
0.302 |
|
| 2016 |
Lemmens R, Hamilton SA, Liebeskind DS, Tomsick TA, Demchuk AM, Nogueira RG, Marks MP, Jahan R, Gralla J, Yoo AJ, Yeatts SD, Palesch YY, Saver JL, Pereira VM, Broderick JP, et al. Effect of endovascular reperfusion in relation to site of arterial occlusion. Neurology. PMID 26802090 DOI: 10.1212/Wnl.0000000000002399 |
0.316 |
|
| 2016 |
Broderick JP, Berkhemer OA, Palesch YY, Dippel DWJ, Foster LD, Roos YBWEM, Lugt Avd, Tomsick TA, Majoie CBLM, Zwam WHv, Demchuk AM, Oostenbrugge RJv, Khatri P, Lingsma HF, Hill MD, et al. Erratum : Endovascular therapy is effective and safe for patients with severe ischemic stroke: Pooled analysis of Interventional Management of Stroke III and Multicenter Randomized Clinical Trial of Endovascular Therapy for Acute Ischemic Stroke in the Netherlands Data (Stroke (2015) 46 (3416-3422) DOI: 10.1161/STROKEAHA.115.011397) Stroke. 47. PMID 26712956 DOI: 10.1161/Str.0000000000000091 |
0.414 |
|
| 2015 |
Broderick JP, Palesch YY, Janis LS. The National Institutes of Health StrokeNet: A User's Guide. Stroke; a Journal of Cerebral Circulation. PMID 26715457 DOI: 10.1161/Strokeaha.115.011743 |
0.408 |
|
| 2015 |
Demaerschalk BM, Kleindorfer DO, Adeoye OM, Demchuk AM, Fugate JE, Grotta JC, Khalessi AA, Levy EI, Palesch YY, Prabhakaran S, Saposnik G, Saver JL, Smith EE. Scientific Rationale for the Inclusion and Exclusion Criteria for Intravenous Alteplase in Acute Ischemic Stroke: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke; a Journal of Cerebral Circulation. PMID 26696642 DOI: 10.1161/Str.0000000000000086 |
0.393 |
|
| 2015 |
Fan L, Yeatts SD, Wolf BJ, McClure LA, Selim M, Palesch YY. The impact of covariate misclassification using generalized linear regression under covariate-adaptive randomization. Statistical Methods in Medical Research. PMID 26596352 DOI: 10.1177/0962280215616405 |
0.302 |
|
| 2015 |
Broderick JP, Berkhemer OA, Palesch YY, Dippel DW, Foster LD, Roos YB, van der Lugt A, Tomsick TA, Majoie CB, van Zwam WH, Demchuk AM, van Oostenbrugge RJ, Khatri P, Lingsma HF, Hill MD, et al. Endovascular Therapy Is Effective and Safe for Patients With Severe Ischemic Stroke: Pooled Analysis of Interventional Management of Stroke III and Multicenter Randomized Clinical Trial of Endovascular Therapy for Acute Ischemic Stroke in the Netherlands Data. Stroke; a Journal of Cerebral Circulation. PMID 26486865 DOI: 10.1161/Strokeaha.115.011397 |
0.417 |
|
| 2015 |
Hill MD, Martin RH, Palesch YY, Moy CS, Tamariz D, Ryckborst KJ, Jones EB, Weisman D, Pettigrew C, Ginsberg MD. Albumin Administration in Acute Ischemic Stroke: Safety Analysis of the ALIAS Part 2 Multicenter Trial. Plos One. 10: e0131390. PMID 26325387 DOI: 10.1371/Journal.Pone.0131390 |
0.434 |
|
| 2015 |
Tomsick TA, Foster LD, Liebeskind DS, Hill MD, Carrozella J, Goyal M, von Kummer R, Demchuk AM, Dzialowski I, Puetz V, Jovin T, Morales H, Palesch YY, Broderick J, Khatri P, et al. Outcome Differences between Intra-Arterial Iso- and Low-Osmolality Iodinated Radiographic Contrast Media in the Interventional Management of Stroke III Trial. Ajnr. American Journal of Neuroradiology. 36: 2074-81. PMID 26228892 DOI: 10.3174/Ajnr.A4421 |
0.377 |
|
| 2015 |
Liebeskind DS, Albers GW, Crawford K, Derdeyn CP, George MS, Palesch YY, Toga AW, Warach S, Zhao W, Brott TG, Sacco RL, Khatri P, Saver JL, Cramer SC, Wolf SL, et al. Imaging in StrokeNet: Realizing the Potential of Big Data. Stroke; a Journal of Cerebral Circulation. 46: 2000-6. PMID 26045600 DOI: 10.1161/Strokeaha.115.009479 |
0.379 |
|
| 2015 |
Weng Y, Palesch YY, DeSantis SM, Zhao W. Assessing the Impact of Safety Monitoring on the Efficacy Analysis in Large Phase III Group Sequential Trials with Non-Trivial Safety Event Rate. Journal of Biopharmaceutical Statistics. PMID 26010228 DOI: 10.1080/10543406.2015.1052473 |
0.757 |
|
| 2015 |
Palesch YY, Yeatts SD, Tomsick TA, Foster LD, Demchuk AM, Khatri P, Hill MD, Jauch EC, Jovin TG, Yan B, von Kummer R, Molina CA, Goyal M, Schonewille WJ, Mazighi M, et al. Twelve-Month Clinical and Quality-of-Life Outcomes in the Interventional Management of Stroke III Trial. Stroke; a Journal of Cerebral Circulation. 46: 1321-7. PMID 25858239 DOI: 10.1161/Strokeaha.115.009180 |
0.435 |
|
| 2015 |
Georgiadis AL, Palesch YY, Zygun D, Hemphill JC, Robertson CS, Leroux PD, Suarez JI. Multi-modality neuro-monitoring: conventional clinical trial design. Neurocritical Care. 22: 369-77. PMID 25832350 DOI: 10.1007/S12028-015-0134-9 |
0.37 |
|
| 2015 |
Nowacki AS, Zhao W, Palesch YY. A surrogate-primary replacement algorithm for response-adaptive randomization in stroke clinical trials. Statistical Methods in Medical Research. PMID 25586325 DOI: 10.1177/0962280214567142 |
0.597 |
|
| 2015 |
Adeoye O, Sucharew H, Khoury J, Tomsick T, Khatri P, Palesch Y, Schmit PA, Pancioli AM, Broderick JP. Recombinant tissue-type plasminogen activator plus eptifibatide versus recombinant tissue-type plasminogen activator alone in acute ischemic stroke: propensity score-matched post hoc analysis. Stroke; a Journal of Cerebral Circulation. 46: 461-4. PMID 25523054 DOI: 10.1161/Strokeaha.114.006743 |
0.39 |
|
| 2015 |
Zhao W, Hill MD, Palesch Y. Minimal sufficient balance-a new strategy to balance baseline covariates and preserve randomness of treatment allocation. Statistical Methods in Medical Research. 24: 989-1002. PMID 22287602 DOI: 10.1177/0962280212436447 |
0.45 |
|
| 2015 |
Ciolino JD, Martin RH, Zhao W, Hill MD, Jauch EC, Palesch YY. Measuring continuous baseline covariate imbalances in clinical trial data. Statistical Methods in Medical Research. 24: 255-72. PMID 21865270 DOI: 10.1177/0962280211416038 |
0.372 |
|
| 2014 |
Palesch YY. Some common misperceptions about P values. Stroke; a Journal of Cerebral Circulation. 45: e244-6. PMID 25378423 DOI: 10.1161/Strokeaha.114.006138 |
0.309 |
|
| 2014 |
Tomsick TA, Yeatts SD, Liebeskind DS, Carrozzella J, Foster L, Goyal M, von Kummer R, Hill MD, Demchuk AM, Jovin T, Yan B, Zaidat OO, Schonewille W, Engelter S, Martin R, ... ... Palesch YY, et al. Endovascular revascularization results in IMS III: intracranial ICA and M1 occlusions. Journal of Neurointerventional Surgery. PMID 25342652 DOI: 10.1136/Neurintsurg-2014-011318 |
0.319 |
|
| 2014 |
Broderick JP, Palesch YY, Demchuk AM, Yeatts SD, Khatri P, Hill MD, Jauch EC, Jovin TG, Yan B, von Kummer R, Molina CA, Goyal M, Mazighi M, Schonewille WJ, Engelter ST, et al. Evolution of practice during the Interventional Management of Stroke III Trial and implications for ongoing trials. Stroke; a Journal of Cerebral Circulation. 45: 3606-11. PMID 25325911 DOI: 10.1161/Strokeaha.114.005952 |
0.405 |
|
| 2014 |
Elm JJ, Palesch Y, Easton JD, Lindblad A, Barsan W, Silbergleit R, Conwit R, Dillon C, Farrant M, Battenhouse H, Perlmutter A, Johnston SC. Screen failure data in clinical trials: Are screening logs worth it? Clinical Trials (London, England). 11: 467-472. PMID 24925082 DOI: 10.1177/1740774514538706 |
0.611 |
|
| 2014 |
Demchuk AM, Goyal M, Yeatts SD, Carrozzella J, Foster LD, Qazi E, Hill MD, Jovin TG, Ribo M, Yan B, Zaidat OO, Frei D, von Kummer R, Cockroft KM, Khatri P, ... ... Palesch YY, et al. Recanalization and clinical outcome of occlusion sites at baseline CT angiography in the Interventional Management of Stroke III trial. Radiology. 273: 202-10. PMID 24895878 DOI: 10.1148/Radiol.14132649 |
0.4 |
|
| 2014 |
Simpson KN, Simpson AN, Mauldin PD, Hill MD, Yeatts SD, Spilker JA, Foster LD, Khatri P, Martin R, Jauch EC, Kleindorfer D, Palesch YY, Broderick JP. Drivers of costs associated with reperfusion therapy in acute stroke: the Interventional Management of Stroke III Trial. Stroke; a Journal of Cerebral Circulation. 45: 1791-8. PMID 24876261 DOI: 10.1161/Strokeaha.113.003874 |
0.375 |
|
| 2014 |
Khatri P, Yeatts SD, Mazighi M, Broderick JP, Liebeskind DS, Demchuk AM, Amarenco P, Carrozzella J, Spilker J, Foster LD, Goyal M, Hill MD, Palesch YY, Jauch EC, Haley EC, et al. Time to angiographic reperfusion and clinical outcome after acute ischaemic stroke: an analysis of data from the Interventional Management of Stroke (IMS III) phase 3 trial. The Lancet. Neurology. 13: 567-74. PMID 24784550 DOI: 10.1016/S1474-4422(14)70066-3 |
0.457 |
|
| 2014 |
Yeatts SD, Martin RH, Coffey CS, Lyden PD, Foster LD, Woolson RF, Broderick JP, Di Tullio MR, Jungreis CA, Palesch YY. Challenges of decision making regarding futility in a randomized trial: the Interventional Management of Stroke III experience. Stroke; a Journal of Cerebral Circulation. 45: 1408-14. PMID 24699059 DOI: 10.1161/Strokeaha.113.003925 |
0.453 |
|
| 2014 |
Ciolino JD, Martin RH, Zhao W, Jauch EC, Hill MD, Palesch YY. Continuous covariate imbalance and conditional power for clinical trial interim analyses. Contemporary Clinical Trials. 38: 9-18. PMID 24607294 DOI: 10.1016/J.Cct.2014.02.007 |
0.386 |
|
| 2014 |
Liebeskind DS, Tomsick TA, Foster LD, Yeatts SD, Carrozzella J, Demchuk AM, Jovin TG, Khatri P, von Kummer R, Sugg RM, Zaidat OO, Hussain SI, Goyal M, Menon BK, Al Ali F, ... ... Palesch YY, et al. Collaterals at angiography and outcomes in the Interventional Management of Stroke (IMS) III trial. Stroke; a Journal of Cerebral Circulation. 45: 759-64. PMID 24473178 DOI: 10.1161/Strokeaha.113.004072 |
0.422 |
|
| 2014 |
Hill MD, Demchuk AM, Goyal M, Jovin TG, Foster LD, Tomsick TA, von Kummer R, Yeatts SD, Palesch YY, Broderick JP. Alberta Stroke Program early computed tomography score to select patients for endovascular treatment: Interventional Management of Stroke (IMS)-III Trial. Stroke; a Journal of Cerebral Circulation. 45: 444-9. PMID 24335227 DOI: 10.1161/Strokeaha.113.003580 |
0.418 |
|
| 2014 |
Desantis SM, Lazaridis C, Palesch Y, Ramakrishnan V. Regression analysis of ordinal stroke clinical trial outcomes: an application to the NINDS t-PA trial. International Journal of Stroke : Official Journal of the International Stroke Society. 9: 226-31. PMID 23803174 DOI: 10.1111/Ijs.12052 |
0.414 |
|
| 2013 |
Ciolino JD, Martin RH, Zhao W, Jauch EC, Hill MD, Palesch YY. Covariate imbalance and adjustment for logistic regression analysis of clinical trial data. Journal of Biopharmaceutical Statistics. 23: 1383-402. PMID 24138438 DOI: 10.1080/10543406.2013.834912 |
0.346 |
|
| 2013 |
Ginsberg MD, Palesch YY, Hill MD, Martin RH, Moy CS, Barsan WG, Waldman BD, Tamariz D, Ryckborst KJ. High-dose albumin treatment for acute ischaemic stroke (ALIAS) Part 2: a randomised, double-blind, phase 3, placebo-controlled trial. The Lancet. Neurology. 12: 1049-58. PMID 24076337 DOI: 10.1016/S1474-4422(13)70223-0 |
0.44 |
|
| 2013 |
Yeatts SD, Palesch YY, Moy CS, Selim M. High dose deferoxamine in intracerebral hemorrhage (HI-DEF) trial: rationale, design, and methods. Neurocritical Care. 19: 257-66. PMID 23943316 DOI: 10.1007/S12028-013-9861-Y |
0.351 |
|
| 2013 |
Johnston SC, Easton JD, Farrant M, Barsan W, Battenhouse H, Conwit R, Dillon C, Elm J, Lindblad A, Morgenstern L, Poisson SN, Palesch Y. Platelet-oriented inhibition in new TIA and minor ischemic stroke (POINT) trial: rationale and design. International Journal of Stroke : Official Journal of the International Stroke Society. 8: 479-83. PMID 23879752 DOI: 10.1111/Ijs.12129 |
0.637 |
|
| 2013 |
Broderick JP, Palesch YY, Demchuk AM, Yeatts SD, Khatri P, Hill MD, Jauch EC, Jovin TG, Yan B, Silver FL, von Kummer R, Molina CA, Demaerschalk BM, Budzik R, Clark WM, et al. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. The New England Journal of Medicine. 368: 893-903. PMID 23390923 DOI: 10.1056/Nejmoa1214300 |
0.315 |
|
| 2013 |
Hussein HM, Tariq NA, Palesch YY, Qureshi AI. Reliability of hematoma volume measurement at local sites in a multicenter acute intracerebral hemorrhage clinical trial. Stroke; a Journal of Cerebral Circulation. 44: 237-9. PMID 23233387 DOI: 10.1161/Strokeaha.112.667220 |
0.331 |
|
| 2012 |
Sato S, Yamamoto H, Qureshi AI, Palesch YY, Toyoda K. [Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH)-II at Japan site: study design and advance construction of domestic research network]. Rinshō Shinkeigaku = Clinical Neurology. 52: 642-50. PMID 22989898 DOI: 10.5692/Clinicalneurol.52.642 |
0.447 |
|
| 2012 |
Elm JJ, Palesch YY, Koch GG, Hinson V, Ravina B, Zhao W. Flexible analytical methods for adding a treatment arm mid-study to an ongoing clinical trial. Journal of Biopharmaceutical Statistics. 22: 758-72. PMID 22651113 DOI: 10.1080/10543406.2010.528103 |
0.603 |
|
| 2012 |
Weng Y, Zhao W, Palesch Y. Impact of safety monitoring on error probabilities of binary efficacy outcome analyses in large phase III group sequential trials. Pharmaceutical Statistics. 11: 310-7. PMID 22589042 DOI: 10.1002/Pst.1520 |
0.759 |
|
| 2012 |
Meurer WJ, Lewis RJ, Tagle D, Fetters MD, Legocki L, Berry S, Connor J, Durkalski V, Elm J, Zhao W, Frederiksen S, Silbergleit R, Palesch Y, Berry DA, Barsan WG. An overview of the adaptive designs accelerating promising trials into treatments (ADAPT-IT) project. Annals of Emergency Medicine. 60: 451-7. PMID 22424650 DOI: 10.1016/J.Annemergmed.2012.01.020 |
0.732 |
|
| 2012 |
Silbergleit R, Durkalski V, Lowenstein D, Conwit R, Pancioli A, Palesch Y, Barsan W. Intramuscular versus intravenous therapy for prehospital status epilepticus. The New England Journal of Medicine. 366: 591-600. PMID 22335736 DOI: 10.1056/Nejmoa1107494 |
0.601 |
|
| 2012 |
Hall CE, Mirski M, Palesch YY, Diringer MN, Qureshi AI, Robertson CS, Geocadin R, Wijman CAC, Le Roux PD, Suarez JI. Clinical trial design in the neurocritical care unit Neurocritical Care. 16: 6-19. PMID 21792753 DOI: 10.1007/S12028-011-9608-6 |
0.33 |
|
| 2012 |
Zhao W, Weng Y, Wu Q, Palesch Y. Quantitative comparison of randomization designs in sequential clinical trials based on treatment balance and allocation randomness. Pharmaceutical Statistics. 11: 39-48. PMID 21544929 DOI: 10.1002/Pst.493 |
0.748 |
|
| 2012 |
Connelly B, Dillon C, Kim J, Patterson L, Palesch Y, Qureshi A. Using Standardized Web Based Tests in Clinical Trials To Improve Investigator and Coordinator Protocol Familiarity: Experience from Antihypertensive Treatment of Acute Cerebral Hemorrhage II Trial (P02.186) Neurology. 78: P02.186-P02.186. DOI: 10.1212/Wnl.78.1_Meetingabstracts.P02.186 |
0.34 |
|
| 2012 |
Brown DL, Johnston KC, Palesch YY. Acute ischemic stroke Clinical Trials in Neurology: Design, Conduct, Analysis. 242-256. DOI: 10.1017/CBO9781139032445.023 |
0.314 |
|
| 2011 |
Selim M, Yeatts S, Goldstein JN, Gomes J, Greenberg S, Morgenstern LB, Schlaug G, Torbey M, Waldman B, Xi G, Palesch Y. Safety and tolerability of deferoxamine mesylate in patients with acute intracerebral hemorrhage. Stroke; a Journal of Cerebral Circulation. 42: 3067-74. PMID 21868742 DOI: 10.1161/Strokeaha.111.617589 |
0.344 |
|
| 2011 |
Qureshi AI, Palesch YY. Antihypertensive treatment of acute cerebral hemorrhage (ATACH) II: Design, methods, and rationale Neurocritical Care. 15: 559-576. PMID 21626077 DOI: 10.1007/S12028-011-9538-3 |
0.466 |
|
| 2011 |
Hill MD, Martin RH, Palesch YY, Tamariz D, Waldman BD, Ryckborst KJ, Moy CS, Barsan WG, Ginsberg MD. The Albumin in Acute Stroke Part 1 Trial: an exploratory efficacy analysis. Stroke; a Journal of Cerebral Circulation. 42: 1621-5. PMID 21546491 DOI: 10.1161/Strokeaha.110.610980 |
0.472 |
|
| 2011 |
Ginsberg MD, Palesch YY, Martin RH, Hill MD, Moy CS, Waldman BD, Yeatts SD, Tamariz D, Ryckborst K. The albumin in acute stroke (ALIAS) multicenter clinical trial: safety analysis of part 1 and rationale and design of part 2. Stroke; a Journal of Cerebral Circulation. 42: 119-27. PMID 21164127 DOI: 10.1161/Strokeaha.110.596072 |
0.457 |
|
| 2011 |
Ciolino J, Zhao W, Martin R, Palesch Y. Quantifying the cost in power of ignoring continuous covariate imbalances in clinical trial randomization. Contemporary Clinical Trials. 32: 250-9. PMID 21078415 DOI: 10.1016/J.Cct.2010.11.005 |
0.438 |
|
| 2011 |
Furie KL, Kasner SE, Adams RJ, Albers GW, Bush RL, Fagan SC, Halperin JL, Johnston SC, Katzan I, Kernan WN, Mitchell PH, Ovbiagele B, Palesch YY, Sacco RL, Schwamm LH, et al. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the american heart association/american stroke association. Stroke; a Journal of Cerebral Circulation. 42: 227-76. PMID 20966421 DOI: 10.1161/Str.0B013E3181F7D043 |
0.368 |
|
| 2011 |
Tilley BC, Palesch YY. Conduct of Stroke-Related Clinical Trials Stroke. 1192-1203. DOI: 10.1016/B978-1-4160-5478-8.10060-0 |
0.324 |
|
| 2010 |
Zhao W, Waldman BD, Dillon C, Pauls K, Kim J, Patterson L, Ginsberg MD, Hill MD, Palesch Y. A web-based medical safety reporting system for a large multicenter clinical trial: the ALIAS experience. Contemporary Clinical Trials. 31: 536-43. PMID 20828636 DOI: 10.1016/J.Cct.2010.08.010 |
0.351 |
|
| 2010 |
Khatri P, Kleindorfer DO, Yeatts SD, Saver JL, Levine SR, Lyden PD, Moomaw CJ, Palesch YY, Jauch EC, Broderick JP. Strokes with minor symptoms: an exploratory analysis of the National Institute of Neurological Disorders and Stroke recombinant tissue plasminogen activator trials. Stroke; a Journal of Cerebral Circulation. 41: 2581-6. PMID 20814000 DOI: 10.1161/Strokeaha.110.593632 |
0.417 |
|
| 2010 |
Zhao W, Ciolino J, Palesch Y. Step-forward randomization in multicenter emergency treatment clinical trials. Academic Emergency Medicine : Official Journal of the Society For Academic Emergency Medicine. 17: 659-65. PMID 20624149 DOI: 10.1111/J.1553-2712.2010.00746.X |
0.448 |
|
| 2010 |
Bath PM, Cotton D, Martin RH, Palesch Y, Yusuf S, Sacco R, Diener HC, Estol C, Roberts R. Effect of combined aspirin and extended-release dipyridamole versus clopidogrel on functional outcome and recurrence in acute, mild ischemic stroke: PRoFESS subgroup analysis. Stroke; a Journal of Cerebral Circulation. 41: 732-8. PMID 20181679 DOI: 10.1161/Strokeaha.109.564906 |
0.394 |
|
| 2010 |
Zhao W, Durkalski V, Pauls K, Dillon C, Kim J, Kolk D, Silbergleit R, Stevenson V, Palesch Y. An electronic regulatory document management system for a clinical trial network. Contemporary Clinical Trials. 31: 27-33. PMID 19782156 DOI: 10.1016/J.Cct.2009.09.005 |
0.628 |
|
| 2010 |
Novitzke J, Martin R, Palesch YY, Qureshi AI. Clinical site activation times for multicenter clinical trials: Lessons learned from the Antihypertensive Treatment of Acute Cerebral Hemorrhage trial Journal of Neuroscience Nursing. 42: E17-E22. DOI: 10.1097/Jnn.0B013E3181D5Befa |
0.32 |
|
| 2009 |
Bath PM, Martin RH, Palesch Y, Cotton D, Yusuf S, Sacco R, Diener HC, Toni D, Estol C, Roberts R. Effect of telmisartan on functional outcome, recurrence, and blood pressure in patients with acute mild ischemic stroke: a PRoFESS subgroup analysis. Stroke; a Journal of Cerebral Circulation. 40: 3541-6. PMID 19797187 DOI: 10.1161/Strokeaha.109.555623 |
0.383 |
|
| 2009 |
Huang P, Goetz CG, Woolson RF, Tilley B, Kerr D, Palesch Y, Elm J, Ravina B, Bergmann KJ, Kieburtz K. Using global statistical tests in long-term Parkinson's disease clinical trials. Movement Disorders : Official Journal of the Movement Disorder Society. 24: 1732-9. PMID 19514076 DOI: 10.1002/Mds.22645 |
0.612 |
|
| 2009 |
Hedden SL, Woolson RF, Carter RE, Palesch Y, Upadhyaya HP, Malcolm RJ. The impact of loss to follow-up on hypothesis tests of the treatment effect for several statistical methods in substance abuse clinical trials. Journal of Substance Abuse Treatment. 37: 54-63. PMID 19008067 DOI: 10.1016/J.Jsat.2008.09.011 |
0.335 |
|
| 2008 |
Diener HC, Sacco RL, Yusuf S, Cotton D, Ounpuu S, Lawton WA, Palesch Y, Martin RH, Albers GW, Bath P, Bornstein N, Chan BP, Chen ST, Cunha L, Dahlöf B, et al. Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study. The Lancet. Neurology. 7: 875-84. PMID 18757238 DOI: 10.1016/S1474-4422(08)70198-4 |
0.403 |
|
| 2008 |
Yusuf S, Diener HC, Sacco RL, Cotton D, Ounpuu S, Lawton WA, Palesch Y, Martin RH, Albers GW, Bath P, Bornstein N, Chan BP, Chen ST, Cunha L, Dahlöf B, et al. Telmisartan to prevent recurrent stroke and cardiovascular events. The New England Journal of Medicine. 359: 1225-37. PMID 18753639 DOI: 10.1056/Nejmoa0804593 |
0.368 |
|
| 2008 |
Sacco RL, Diener HC, Yusuf S, Cotton D, Ounpuu S, Lawton WA, Palesch Y, Martin RH, Albers GW, Bath P, Bornstein N, Chan BP, Chen ST, Cunha L, Dahlöf B, et al. Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. The New England Journal of Medicine. 359: 1238-51. PMID 18753638 DOI: 10.1056/Nejmoa0805002 |
0.377 |
|
| 2008 |
Mauldin PD, Simpson KN, Palesch YY, Spilker JS, Hill MD, Khatri P, Broderick JP. Design of the economic evaluation for the Interventional Management of Stroke (III) trial. International Journal of Stroke : Official Journal of the International Stroke Society. 3: 138-44. PMID 18706008 DOI: 10.1111/J.1747-4949.2008.00190.X |
0.397 |
|
| 2008 |
Miller SW, Palesch YY. Comments regarding the recent OAST article. Stroke; a Journal of Cerebral Circulation. 39: e14; author reply e1. PMID 18048843 DOI: 10.1161/Strokeaha.107.500355 |
0.361 |
|
| 2007 |
Hill MD, Moy CS, Palesch YY, Martin R, Dillon CR, Waldman BD, Patterson L, Mendez IM, Ryckborst KJ, Tamariz D, Ginsberg MD. The albumin in acute stroke trial (ALIAS); design and methodology. International Journal of Stroke : Official Journal of the International Stroke Society. 2: 214-9. PMID 18705947 DOI: 10.1111/J.1747-4949.2007.00143.X |
0.439 |
|
| 2007 |
Guimaraes P, Palesch Y. Power and sample size simulations for Randomized Play-the-Winner rules Contemporary Clinical Trials. 28: 487-499. PMID 17321219 DOI: 10.1016/J.Cct.2007.01.006 |
0.346 |
|
| 2006 |
Ginsberg MD, Palesch YY, Hill MD. The ALIAS (ALbumin In Acute Stroke) Phase III randomized multicentre clinical trial: design and progress report. Biochemical Society Transactions. 34: 1323-6. PMID 17073812 DOI: 10.1042/Bst0341323 |
0.464 |
|
| 2006 |
Ginsberg MD, Hill MD, Palesch YY, Ryckborst KJ, Tamariz D. The ALIAS Pilot Trial: a dose-escalation and safety study of albumin therapy for acute ischemic stroke--I: Physiological responses and safety results. Stroke; a Journal of Cerebral Circulation. 37: 2100-6. PMID 16809571 DOI: 10.1161/01.Str.0000231388.72646.05 |
0.402 |
|
| 2006 |
Palesch YY, Hill MD, Ryckborst KJ, Tamariz D, Ginsberg MD. The ALIAS Pilot Trial: a dose-escalation and safety study of albumin therapy for acute ischemic stroke--II: neurologic outcome and efficacy analysis. Stroke; a Journal of Cerebral Circulation. 37: 2107-14. PMID 16809570 DOI: 10.1161/01.STR.0000231389.34701.b5 |
0.301 |
|
| 2006 |
Pavlakis SG, Sacco R, Levine SR, Meschia JF, Palesch Y, Tilley BC, Adams HP. Lessons from adult stroke trials. Pediatric Neurology. 34: 446-9. PMID 16765822 DOI: 10.1016/J.Pediatrneurol.2005.09.010 |
0.448 |
|
| 2006 |
Tilley BC, Palesch YY, Kieburtz K, Ravina B, Huang P, Elm JJ, Shannon K, Wooten GF, Tanner CM, Goetz GC. Optimizing the ongoing search for new treatments for Parkinson disease: using futility designs. Neurology. 66: 628-33. PMID 16534099 DOI: 10.1212/01.Wnl.0000201251.33253.Fb |
0.621 |
|
| 2006 |
Ravina B, Palesch Y. The Phase II Futility Clinical Trial Design Progress in Neurotherapeutics and Neuropsychopharmacology. 2: 27-38. DOI: 10.1017/S1748232106000048 |
0.357 |
|
| 2005 |
Guimaraes P, Kieburtz K, Goetz CG, Elm JJ, Palesch YY, Huang P, Ravina B, Tanner CM, Tilley BC. Non-linearity of Parkinson's disease progression: implications for sample size calculations in clinical trials. Clinical Trials (London, England). 2: 509-18. PMID 16422311 DOI: 10.1191/1740774505Cn125Oa |
0.608 |
|
| 2005 |
Palesch YY, Tilley BC, Sackett DL, Johnston KC, Woolson R. Applying a phase II futility study design to therapeutic stroke trials. Stroke; a Journal of Cerebral Circulation. 36: 2410-4. PMID 16224086 DOI: 10.1161/01.Str.0000185718.26377.07 |
0.392 |
|
| 2005 |
Elm JJ, Goetz CG, Ravina B, Shannon K, Wooten GF, Tanner CM, Palesch YY, Huang P, Guimaraes P, Kamp C, Tilley BC, Kieburtz K. A responsive outcome for Parkinson's disease neuroprotection futility studies. Annals of Neurology. 57: 197-203. PMID 15668964 DOI: 10.1002/Ana.20361 |
0.583 |
|
| 2005 |
Ravina B, Eidelberg D, Ahlskog JE, Albin RL, Brooks DJ, Carbon M, Dhawan V, Feigin A, Fahn S, Guttman M, Gwinn-Hardy K, McFarland H, Innis R, Katz RG, Kieburtz K, ... ... Palesch Y, et al. The role of radiotracer imaging in Parkinson disease. Neurology. 64: 208-15. PMID 15668415 DOI: 10.1212/01.Wnl.0000149403.14458.7F |
0.305 |
|
| 2005 |
Ginsberg MD, Hill MD, Palesch YY, Ryckborst KJ, Tamariz D. Albumin therapy for neuroprotection in ischemic stroke: Alias I trial Journal of Cerebral Blood Flow & Metabolism. 25: S115-S115. DOI: 10.1038/Sj.Jcbfm.9591524.0115 |
0.353 |
|
| 2004 |
Palesch YY, Tilley BC. An efficient multi-stage, single-arm Phase II futility design for ALS. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group On Motor Neuron Diseases. 5: 55-6. PMID 15512874 DOI: 10.1080/17434470410020003 |
0.416 |
|
| 2004 |
Gillanders WE, Mikhitarian K, Hebert R, Mauldin PD, Palesch Y, Walters C, Urist MM, Mann GB, Doherty G, Herrmann VM, Hill AD, Eremin O, El-Sheemy M, Orr RK, Valle AA, et al. Molecular detection of micrometastatic breast cancer in histopathology-negative axillary lymph nodes correlates with traditional predictors of prognosis: an interim analysis of a prospective multi-institutional cohort study. Annals of Surgery. 239: 828-37; discussion 8. PMID 15166962 DOI: 10.1097/01.Sla.0000128687.59439.D6 |
0.635 |
|
| 2004 |
Cotton PB, Durkalski VL, Pineau BC, Palesch YY, Mauldin PD, Hoffman B, Vining DJ, Small WC, Affronti J, Rex D, Kopecky KK, Ackerman S, Burdick JS, Brewington C, Turner MA, et al. Computed tomographic colonography (virtual colonoscopy): a multicenter comparison with standard colonoscopy for detection of colorectal neoplasia. Jama. 291: 1713-9. PMID 15082698 DOI: 10.1001/Jama.291.14.1713 |
0.578 |
|
| 2004 |
McRae AL, Sonne SC, Brady KT, Durkalski V, Palesch Y. A Randomized, Placebo-controlled trial of Buspirone for the Treatment of Anxiety in Opioid-dependent Individuals American Journal On Addictions. 13: 53-63. PMID 14766438 DOI: 10.1080/10550490490265325 |
0.589 |
|
| 2004 |
Duan Y, Lipkovich I, Ahmed S, Ahl J, Hardy T, Haldane D, Baker R, Tohen M, Liu-Seifert H, Healey K, Kinon BJ, Ahmed S, Lipkovich IA, Tohen MF, Hoffmann V, ... ... Palesch YY, et al. Abstracts from ASENT 2004 Annual Meeting March 11–13, 2004 Neurorx. 1: 506-514. DOI: 10.1602/Neurorx.1.4.506 |
0.466 |
|
| 2004 |
Cotton PB, Durkalski VL, Pineau BC, Palesch YY, Mauldin PD, Hoffman B, Vining DJ, Small WC, Affronti J, Rex D, Kopecky KK, Ackerman S, Burdick JS, Brewington C, Turner MA, et al. Computed tomographic colonography: What results should we believe? Evidence-Based Gastroenterology. 5: 84-85. DOI: 10.1097/00132579-200408000-00006 |
0.492 |
|
| 2004 |
Duan Y, Lipkovich I, Ahmed S, Ahl J, Hardy T, Haldane D, Baker R, Tohen M, Liu-Seifert H, Healey K, Kinon BJ, Ahmed S, Lipkovich IA, Tohen MF, Hoffmann V, ... ... Palesch YY, et al. Abstracts from ASENT 2004 Annual Meeting March 11–13, 2004 Neurotherapeutics. 1: 506-514. DOI: 10.1007/BF03206636 |
0.466 |
|
| 2003 |
Durkalski VL, Palesch YY, Lipsitz SR, Rust PF. Analysis of clustered matched-pair data. Statistics in Medicine. 22: 2417-28. PMID 12872299 DOI: 10.1002/Sim.1438 |
0.569 |
|
| 2003 |
Durkalski VL, Palesch YY, Lipsitz SR, Rust PF. Analysis of clustered matched-pair data for a non-inferiority study design. Statistics in Medicine. 22: 279-90. PMID 12520562 DOI: 10.1002/Sim.1385 |
0.586 |
|
| 2002 |
Durkalski VL, Palesch YY, Pineau BC, Vining DJ, Cotton PB. The virtual colonoscopy study: a large multicenter clinical trial designed to compare two diagnostic screening procedures. Controlled Clinical Trials. 23: 570-83. PMID 12392872 DOI: 10.1016/S0197-2456(02)00232-5 |
0.622 |
|
| 2002 |
Turrisi AT, Hawes RH, Palesch Y, Redmond C, Williams T, Reed C, Mauldin P, Cotton PB. The SORTIE trial: palliation with stent (S) or radiation therapy (RT) 20 Gy in 5 fractions intervention for esophageal cancer dysphagia: a multicenter trial for T-4, M+/- squamous or adenocarcinoma of the esophagus. a randomized trial relief from dysphagia and quality of life (QOL) analysis International Journal of Radiation Oncology Biology Physics. 54: 132. DOI: 10.1016/S0360-3016(02)03284-4 |
0.334 |
|
| 2001 |
Wallace MB, Durkalski VL, Vaughan J, Palesch YY, Libby ED, Jowell PS, Nickl NJ, Schutz SM, Leung JW, Cotton PB. Age and alarm symptoms do not predict endoscopic findings among patients with dyspepsia: a multicentre database study. Gut. 49: 29-34. PMID 11413107 DOI: 10.1136/Gut.49.1.29 |
0.571 |
|
| 2001 |
Hebert RL, Palesch YY, Mauldin PD, Tarnasky PR, Aabakken L, Hennessey W, Cotton PB. DDQ-15 health-related quality of life instrument for patients with digestive disorders Health Services and Outcomes Research Methodology. 2: 137-156. DOI: 10.1023/A:1020106129820 |
0.676 |
|
| 2000 |
Ables AZ, Blumer NA, Valainis GT, Godenick MT, Kajdasz DK, Palesch YY. Fluconazole prophylaxis of severe candida infection in trauma and postsurgical patients: A prospective, double-blind, randomized, placebo- controlled trial Infectious Diseases in Clinical Practice. 9: 169-175. DOI: 10.1097/00019048-200009040-00006 |
0.324 |
|
| 1997 |
Akazawa K, Nakamura T, Palesch Y. Power of logrank test and Cox regression model in clinical trials with heterogeneous samples Statistics in Medicine. 16: 583-597. PMID 9089965 DOI: 10.1002/(Sici)1097-0258(19970315)16:5<583::Aid-Sim433>3.0.Co;2-Z |
0.362 |
|
| 1997 |
Overdyk F, Fishman R, Pinosky M, Hebert R, Palesch Y. A378 Accuracy of Combined Pharmacokinetic/Pharmacodynamic (PK/PD) Model in Predicting Recovery from Propofol/Alfentanil Total Intravenous Anesthesia (TIVA) Anesthesiology. 87: 378A. DOI: 10.1097/00000542-199709001-00378 |
0.631 |
|
| Show low-probability matches. |